GlassScriptPhysician profile
Naresh C Rao
NPI 1952309825
$547.57
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $256 · 2021: $16.05.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $199.75 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $183.66 | 2019-2020 | |
| Abbvie INC. | $42.96 | 2019-2020 | |
| Bioventus LLC | $28.08 | 2019 | |
| Optinose US, INC. | $25.52 | 2019 | |
| Ironshore Pharmaceuticals INC. | $20.00 | 2020 | |
| Phadia US INC. | $16.05 | 2021 | |
| Horizon Therapeutics Plc | $15.91 | 2019 | |
| Adlon Therapeutics L.P. | $15.64 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naresh Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.